1Bhattcharyya N, Marvin PF. Nodal metastasis in major salivary gland cancer: predictive factors and effects on survival. Arch Otolaryngol Head Neck Surg, 2002,128(8) :904-908.
2Frankenthaler RA, Byers RM, Luna MA, et al. Predicting occult lymph node metastasis in parotid cancer. Arch Otolaryngol Head Neck Surg, 1993,119 (5) :517-520.
3Regis De Brito Santos I, Kowalski LP, Cavalcante De Araujo V, et al. Multivariate analysis of risk factors for neck metastases in surgically treated parotid carcinoma. Arch Otolaryngol Head Neck Surg, 2001,127(1) :56-60.
4Zbaren P, Schupbach J, Nuyens M, et al. Carcinoma of the parotid gland. Am J Surg, 2003,186(1) :57-62.
5Harish K. Management of primary malignant epithelial parotid tumors. Surg Oncol, 2004, 13(1) :7-16.
6Armstrong JG, Harriso LB, Thaler HT, et al. The indications for elective treatment of the neck in cancer of the major salivary glands. Cancer, 1992, 69(3) :615-619.
7Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group, Head Neck, 2004, 26 ( 8 ) : 681-692.
